Application deadline: 31/01/2020
Number of vacancies: 1
We seek a computational biologist to lead a newly created Support Unit for different research areas at VHIO, mainly focused on the analysis of genomic and transcriptomic (both RNA-seq and Chip-seq) data from different tumor types including real-time data from patients’ samples.
The successful candidate will have previous experience working with cancer genome databases, including retrieval and data management from public data bases such as EGA, dbGaPde, and an understanding of the complexity of data sharing in large collaborative projects. Applicants should be able to work independently and across multiple projects.
A Bioinformatician with a PhD in biomedical sciences or similar (i.e. at least 3-4 years’ experience and peer-reviewed publications).
Applicants must be proficient in processing and analyzing genomic and transcriptomic data, particularly in oncology.
Experience using GNU/ Linux systems, preferably Ubuntu.
Fluency in R., knowledge of Python and other programing languages will also be favorably considered.
Proficiency in English.
Knowledge of statistical modelling or machine learning, as well as other omics (e.g. proteomics) will also be considered as advantageous.
Salary will be based on the specific profile and experience of the candidate.
Candidates must submit a curriculum vitae and letter of intent via email: email@example.com, including the reference number 36/2019. Please also attach a letter of reference.
Under the leadership of Josep Tabernero, the Vall d’Hebron Institute of Oncology (VHIO), has established itself as a comprehensive cancer center of proven excellence internationally. It is also thanks to VHIO’s optimal organizational structure based on a purely multidisciplinary and translational model that VHIO talents continue to anticipate and tackle the many unresolved questions in combatting this multifaceted and heterogeneous disease.
Located within the Vall d’Hebron Barcelona Hospital Campus, our researchers closely collaborate and interact with Vall d’Hebron physician-scientists. Translational science and clinical research are therefore tightly connected which promotes superb interaction and teamwork which, in turn, accelerates the bench-bedside-bed cycle of knowledge.
This privileged environment affords VHIO direct access to patients as well as the entire spectrum of oncology professionals who care for them, and a second-to-none appreciation of how cancer science can translate into more powerful, targeted treatments and better practice for the care of patients.
VHIO’s pioneering model and programs, coupled with its belief in combining strengths through cross-border collaborations, continue to spur advances in reversing cancer resistance, halting metastatic spread, and more effectively treating even the most undruggable tumor types.
VHIO’s translation toward precision oncology: http://www.vhio.net
Vall d’Hebron Institute Oncology (VHIO) endorses the Requirements and Principles of the European Charter for Researchers, the Code of Conduct for the Recruitment of Researchers promoted by the European Commission and follows Equal Opportunities policies.
On 10th April 2018 VHIO was awarded the “HR Excellence in Research” logo. Our Institute was consequently granted permission to use the HR Excellence in Research Award logo as demonstration of its stimulating and favourable work environment in line with the Charter & Code.